Tag: Cancer
-
Inspired by Nature
This year, the University launched a new Center for Synthetic Biology, making Northwestern one of the top three U.S. destinations for research and education in this area.
-
Guidelines Published for Managing Chronic Pain in Cancer Survivors
An expert panel led by Northwestern Medicine investigator Judith Paice, PhD, RN, developed recommendations to help clinicians manage the chronic pain of cancer survivors.
-
An Update on Lymphoma Research
Faculty from the Division of Hematology/Oncology presented a panel discussion on lymphoma research, treatment and novel trials.
-
Using Stem Cells to Predict Patients’ Responses to Cancer Therapy
New Northwestern Medicine research has shown that reprogrammed stem cells can be used to identify patients with cancer who are likely to experience a dangerous side effect of a common chemotherapy drug.
-
Lurie Cancer Center Launches Health Learning Portal
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University in partnership with Feinberg launched an eHealth Distance Learning Portal on August 1 to encourage global collaborations.
-
Evaluating a Precision Medicine Approach to Treating Advanced Breast Cancer
Identifying mutations in the estrogen receptor (ER) gene can help clinicians choose effective therapies for patients with ER-positive metastatic breast cancer, according to recent research.
-
Studying Blood Test for Early Cancer Detection
Scientists at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University will test Guardant Health’s technology to detect cancer at early stages in high-risk populations.
-
Chandel Awarded NCI Outstanding Investigator Award
Navdeep Chandel, PhD, David W. Cugell Professor of Medicine, has received the National Cancer Institute’s Outstanding Investigator Award to explore how mitochondrial metabolism plays a role in cancer.
-
Collaborating to Explore Cancer Therapy Resistance
The results of a recent study co-authored by C. David James, PhD, uncovered potential new targets for treating glioblastoma, a fatal brain tumor for which there is currently no cure.
-
Stem Cell Method Predicts Patient Response to Cancer Drug
New Northwestern Medicine research has shown that reprogrammed stem cells can be used to identify patients with cancer who are likely to experience a dangerous side effect of a common chemotherapy drug.
